Base
Customs Broker

JDC INTERNATIONAL, INC.

IL

Cross-Source Intelligence

Arrivals (12 mo)

0

0 active ports

Active Ports

0

Distinct US ports with vessel activity

Compliance

Clear

6 lists screened

Data compiled from CBP Licensed Brokers, OpenSanctions, OFAC SDN, BIS Consolidated Screening List · As of 2026-04-26 · Updates daily

Sanctions & Compliance Screening

OFAC Specially Designated Nationals (SDN)

No matches found

Search of the OFAC SDN list for “JDC INTERNATIONAL, INC.” returned no matches.

BIS Consolidated Screening List (CSL)

No matches found

Search of the BIS CSL for “JDC INTERNATIONAL, INC.” returned no matches. This covers the BIS Entity List, Denied Persons List, OFAC SDN, ITAR Debarred, and 10 other U.S. export control lists.

SEC Filings (100)

001-16207
2005-02-11

SEC filing

View on SEC.gov →
001-14888
2011-11-07

COLLABORATIVE DEVELOPMENT AND LICENSE AGREEMENT

View on SEC.gov →
001-14888
2010-05-17

LICENSE AND COLLABORATION AGREEMENT

View on SEC.gov →
333-282197
2024-09-18

EX-10.14

View on SEC.gov →
001-31361
2015-03-16

LICENSE AND DEVELOPMENT AGREEMENT

View on SEC.gov →
377-07271
2024-06-12

SEC filing

View on SEC.gov →
001-36783
2017-03-13

EXHIBIT 10.41

View on SEC.gov →
001-37524
2022-08-15

EX-10.1

View on SEC.gov →
000-50513
2009-08-10

EXHIBIT 10.54

View on SEC.gov →
001-31938
2019-08-07

EX-10.1

View on SEC.gov →
001-31361
2012-01-11

LICENSE AND DEVELOPMENT AGREEMENT

View on SEC.gov →
001-35570
2024-10-09

SEC filing

View on SEC.gov →
333-128059
2005-11-14

EXHIBIT 10.27

View on SEC.gov →
377-02758
2019-10-04

SEC filing

View on SEC.gov →
001-34620
2017-05-08

EX-10.1

View on SEC.gov →
333-114376
2004-12-06

DEVELOPMENT AGREEMENT BETWEEN THE REGISTRANT AND MEDIBIC CO. LTD

View on SEC.gov →
2013-01-29

SEC filing

View on SEC.gov →
333-128059
2005-09-02

EXHIBIT 10.27

View on SEC.gov →
333-234363
2019-10-29

EX-10.19

View on SEC.gov →
000-51462
2006-08-14

DEVELOPMENT AND COMMERCIALIZATION AGREEMENT

View on SEC.gov →
333-229476
2019-02-01

EXHIBIT 99.9

View on SEC.gov →
001-35570
2021-05-17

SEC filing

View on SEC.gov →
333-190728
2014-12-18

EX-10.3

View on SEC.gov →
333-114376
2005-01-28

DEVELOPMENT AGREEMENT

View on SEC.gov →
333-175427
2011-10-26

EX-10.16 LICENSE AGREEMENT BETWEEN THE REGISTRANT & MERRIMACK (BERMUDA)

View on SEC.gov →
000-29815
2011-08-04

EX-10.1

View on SEC.gov →
001-16207
2006-01-27

FORM 10-KSB 2003

View on SEC.gov →
001-33528
2015-02-27

EXHIBIT 10.23

View on SEC.gov →
333-198666
2014-10-06

EX-10.4

View on SEC.gov →
001-33528
2020-07-31

EX-10.2

View on SEC.gov →
377-00668
2014-06-26

SEC filing

View on SEC.gov →
333-198410
2014-08-27

EX-10.9

View on SEC.gov →
001-39425
2021-03-29

EX-10.13

View on SEC.gov →
333-232572
2019-07-22

EX-10.22

View on SEC.gov →
000-53072
2011-05-04

JOINT RESEARCH AND DEVELOPMENT AGREEMENT DATED AS OF APRIL 8, 2011 BY AND BETWEEN EMMAUS MEDICAL, INC. AND CELLSEED, INC.

View on SEC.gov →
001-16207
2006-01-27

FORM 10-KSB 2004

View on SEC.gov →
333-259484
2021-10-18

DEVELOPMENT, OPTION AND LICENSE AGREEMENT BETWEEN ONCOLOGY VENTURE APS AND R-PHARM US OPERATING LLC, DATED MARCH 1, 2019

View on SEC.gov →
000-22705
2010-07-29

COLLABORATION AGREEMENT

View on SEC.gov →
000-29815
2012-03-26

EX-10.25

View on SEC.gov →
333-175427
2011-07-08

EX-10.16 LICENSE AGREEMENT BETWEEN THE REGISTRANT & MERRIMACK (BERMUDA)

View on SEC.gov →
811-22747
2025-05-30

SEC filing

View on SEC.gov →
333-163778
2009-12-16

OPTION AND LICENSE AGREEMENT, BIOGEN IDEC INTERNATIONAL GMBH

View on SEC.gov →
333-232572
2019-07-05

EX-10.25

View on SEC.gov →
333-276350
2024-01-02

EX-10.7

View on SEC.gov →
377-04819
2021-07-02

SEC filing

View on SEC.gov →
000-56337
2021-08-31

PRIMARY DOCUMENT

View on SEC.gov →
000-50344
2011-03-23

OPTION, LICENSE AND DEVELOPMENT AGREEMENT

View on SEC.gov →
333-175427
2011-07-08

EX-10.17 ASSIGNMENT, SUBLICENSE & COLLABORATION AGREEMENT BETWEEN MERRIMACK (BERMUDA) & PHARMAENGINE

View on SEC.gov →
001-38906
2019-12-20

EX-10.6

View on SEC.gov →
000-49839
2013-02-25

EX-10.24

View on SEC.gov →
001-16207
2006-04-17

FROM 10-KSB DECEMBER 31, 2005

View on SEC.gov →
377-03009
2020-01-24

SEC filing

View on SEC.gov →
001-36297
2019-02-28

EXHIBIT 10.42

View on SEC.gov →
001-33876
2023-11-16

EXHIBIT 10.4 - FIFTH AMENDMENT TO LICENSE AGREEMENT, DATED OCTOBER 10, 2023, BY AND BETWEEN ABT HOLDING COMPANY AND HEALIOS K.K.

View on SEC.gov →
333-220337
2017-09-05

EX-10.8

View on SEC.gov →
377-06934
2023-10-27

SEC filing

View on SEC.gov →
333-257794
2021-07-09

EX-10.15

View on SEC.gov →
001-41160
2022-05-17

EXCLUSIVE LICENSE AGREEMENT WITH ONCOHEROES BIOSCIENCE, INC. DATED JANUARY 2, 2022 (DOVITNIB)

View on SEC.gov →
333-257794
2021-07-26

EX-10.15

View on SEC.gov →
001-34655
2012-05-09

OPTION AND LICENSE AGREEMENT

View on SEC.gov →
333-258968
2021-08-20

DEVELOPMENT, OPTION AND LICENSE AGREEMENT BETWEEN ONCOLOGY VENTURE APS AND R-PHARM US OPERATING LLC, DATED MARCH 1, 2019

View on SEC.gov →
333-258968
2021-10-20

DEVELOPMENT, OPTION AND LICENSE AGREEMENT BETWEEN ONCOLOGY VENTURE APS AND R-PHARM US OPERATING LLC, DATED MARCH 1, 2019

View on SEC.gov →
001-41160
2022-05-17

EXCLUSIVE LICENSE AGREEMENT WITH ONCOHEROES BIOSCIENCE, INC. DATED JANUARY 2, 2022 (STENOPARIB)

View on SEC.gov →
001-37620
2021-02-24

EX-10.5

View on SEC.gov →
001-35969
2025-02-27

EX-10.47

View on SEC.gov →
333-220858
2017-10-06

EX-10.15

View on SEC.gov →
000-30235
2018-11-01

EXHIBIT 10.3

View on SEC.gov →
001-10865
2020-11-06

EX-10.1

View on SEC.gov →
333-208842
2016-01-04

COLLABORATIVE DEVELOPMENT AGREEMENT (GENETHON)

View on SEC.gov →
001-39290
2025-04-15

EXHIBIT 10.66

View on SEC.gov →
000-22705
2021-05-05

EX-10.1

View on SEC.gov →
377-02758
2019-09-05

SEC filing

View on SEC.gov →
333-111193
2003-12-16

EXHIBIT 10.12

View on SEC.gov →
001-38052
2018-08-09

EX-10.1

View on SEC.gov →
001-13467
2019-03-07

EX-10.5

View on SEC.gov →
001-34962
2021-03-01

EX-10.24

View on SEC.gov →
000-22705
2016-02-11

EX-10.13

View on SEC.gov →
001-37368
2017-03-13

EX-10.16

View on SEC.gov →
001-38942
2022-11-09

EX-10.38

View on SEC.gov →
001-39290
2024-04-16

EXHIBIT 10.61

View on SEC.gov →
333-237714
2020-04-16

DRUG LICENSE AND DEVELOPMENT AGREEMENT DATED AS OF MAY 23, 2015 WITH ONCOLOGY VENTURE A/S

View on SEC.gov →
333-175427
2011-10-26

EX-10.17 ASSIGNMENT, SUBLICENSE & COLLABORATION AGREEMENT WITH PHARMAENGINE

View on SEC.gov →
001-05438
2013-02-07

EXHIBIT 10.1

View on SEC.gov →
001-36184
2015-11-04

EX-10.1

View on SEC.gov →
001-38871
2021-03-01

EX-10.20

View on SEC.gov →
001-36177
2020-02-28

EX-10.20

View on SEC.gov →
000-19125
2014-05-06

EXHIBIT 10.1

View on SEC.gov →
333-12570
2002-08-07

EXHIBIT 10.14

View on SEC.gov →
333-199069
2014-10-01

EX-10.11

View on SEC.gov →
377-01690
2017-09-22

SEC filing

View on SEC.gov →
001-39011
2020-03-10

EXHIBIT 10.34

View on SEC.gov →
000-30235
2021-05-06

EX-10.1

View on SEC.gov →
001-35223
2017-03-23

EXHIBIT 4.42

View on SEC.gov →
001-36352
2017-08-08

EX-10.1

View on SEC.gov →
333-260565
2021-10-28

CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT, DATED JUNE 21, 2019, BETWEEN THE REGISTRANT AND MSD INTERNATIONAL GMBH

View on SEC.gov →
001-08570
2001-04-30

SUBSIDIARIES OF THE REGISTRANT

View on SEC.gov →
333-187982
2013-04-18

EX-10.18

View on SEC.gov →
000-28782
2010-04-05

EX-10.37

View on SEC.gov →
000-22891
2001-12-17

EXHIBIT 10.1

View on SEC.gov →
333-229476
2019-02-01

EXHIBIT 99.7

View on SEC.gov →

Source: SEC EDGAR Full-Text Search

Registry Details

CBP License
396
License Status
Active
Address
IL
Classification
Customs Broker

Data Sources

Compliance Screening

No sanctions match

No exact name match found in OpenSanctions global database. This is not a guarantee of compliance — always verify through official channels.

Source: OpenSanctions (OFAC SDN, EU, UN, and 40+ additional lists)

Screening Tools

Search the Consolidated Screening List (BIS, OFAC, DDTC) and global sanctions lists.

Search Screening List
← JD Group US Customs BrokerJEAN D DUNCAN INC. →